Skip to main content

3 Reasons to Avoid ALNT and 1 Stock to Buy Instead

ALNT Cover Image

The past six months have been a windfall for Allient’s shareholders. The company’s stock price has jumped 148%, hitting $51.74 per share. This was partly due to its solid quarterly results, and the run-up might have investors contemplating their next move.

Is there a buying opportunity in Allient, or does it present a risk to your portfolio? Get the full stock story straight from our expert analysts, it’s free for active Edge members.

Why Is Allient Not Exciting?

Despite the momentum, we're swiping left on Allient for now. Here are three reasons there are better opportunities than ALNT and a stock we'd rather own.

1. Long-Term Revenue Growth Disappoints

A company’s long-term sales performance can indicate its overall quality. Any business can have short-term success, but a top-tier one grows for years. Regrettably, Allient’s sales grew at a mediocre 7.4% compounded annual growth rate over the last five years. This fell short of our benchmark for the industrials sector.

Allient Quarterly Revenue

2. EPS Took a Dip Over the Last Two Years

Although long-term earnings trends give us the big picture, we like to analyze EPS over a shorter period to see if we are missing a change in the business.

Sadly for Allient, its EPS declined by more than its revenue over the last two years, dropping 12.6%. This tells us the company struggled to adjust to shrinking demand.

Allient Trailing 12-Month EPS (Non-GAAP)

3. Previous Growth Initiatives Haven’t Impressed

Growth gives us insight into a company’s long-term potential, but how capital-efficient was that growth? A company’s ROIC explains this by showing how much operating profit it makes compared to the money it has raised (debt and equity).

Allient historically did a mediocre job investing in profitable growth initiatives. Its five-year average ROIC was 8%, somewhat low compared to the best industrials companies that consistently pump out 20%+.

Allient Trailing 12-Month Return On Invested Capital

Final Judgment

Allient isn’t a terrible business, but it isn’t one of our picks. Following the recent surge, the stock trades at 24.6× forward P/E (or $51.74 per share). Beauty is in the eye of the beholder, but we don’t really see a big opportunity at the moment. We're pretty confident there are superior stocks to buy right now. Let us point you toward one of our all-time favorite software stocks.

High-Quality Stocks for All Market Conditions

Trump’s April 2025 tariff bombshell triggered a massive market selloff, but stocks have since staged an impressive recovery, leaving those who panic sold on the sidelines.

Take advantage of the rebound by checking out our Top 9 Market-Beating Stocks. This is a curated list of our High Quality stocks that have generated a market-beating return of 183% over the last five years (as of March 31st 2025).

Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,545% between March 2020 and March 2025) as well as under-the-radar businesses like the once-small-cap company Comfort Systems (+782% five-year return). Find your next big winner with StockStory today.

StockStory is growing and hiring equity analyst and marketing roles. Are you a 0 to 1 builder passionate about the markets and AI? See the open roles here.

Recent Quotes

View More
Symbol Price Change (%)
AMZN  217.99
-4.04 (-1.82%)
AAPL  257.61
-5.16 (-1.96%)
AMD  229.75
-8.28 (-3.48%)
BAC  51.06
-0.46 (-0.89%)
GOOG  252.20
+0.86 (0.34%)
META  733.15
-0.12 (-0.02%)
MSFT  520.59
+2.93 (0.57%)
NVDA  179.91
-1.25 (-0.69%)
ORCL  273.88
-1.27 (-0.46%)
TSLA  437.86
-4.74 (-1.07%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.